| 2015, Karl |
May. 19th, 2021|09:47 pm |
Jabisti sludina, ka injekcijas naakshoties atkaartot ik peec pusgada.
Toties taas dazhas studijas, kas papeetiijushas " T cell reactivity against SARS-CoV-2 in 20% to 50% of people with no known exposure to the virus", atklaajushas, ka "donor blood specimens obtained in the US between 2015 and 2018, 50% displayed various forms of T cell reactivity to SARS-CoV-2"
https://www.bmj.com/content/370/bmj.m3563
https://reason.com/2020/07/01/covid-19-herd-immunity-is-much-closer-than-antibody-tests-suggest-say-2-new-studies/
Kur nu veel paarsteigums, kad atklaajaas, ka publika Aafrikaa ir imuuna pret ebolu, kaut nekad nav bijushi kontaktaa ar slimniekiem.
"95% of survivors had both antibodies or a T cell response to the virus and there was “no significant reduction” in either antibodies or the T cells more than three years after infection. These results suggest naturally acquired immunity is 10 times higher than that delivered by the new Ebola vaccine"
https://www.theguardian.com/world/2020/oct/19/killer-cells-ebola-immunity-study-could-help-covid-research |
|